PATIENT WITH CROHN’S DISEASE SWITCHES FROM ORAL TO RECTAL CBD AND LOWERS DOSE

I have been following a young male with relatively severe Crohn’s disease. He has been on an assorted group of meds without adequate control.

He first presented to me nearly a year ago and has done very well on CBD whole plant capsules. He required a total daily dose of 95 mg of CBD per day.

Recently he switched over to using rectal administration of 20 mg BID with the same control as with 95 mg orally.

I am not suggesting this is any final answer to the “issues of the rectum”, but it certainly is an important small piece.

We are actively looking for labs that will measure CBD and THC and hopefully the endocannabinoids as well. This would allow us to settle the issues related to rectal vs oral vs oral buccal.

In the meantime, for pelvic or bowel disease, please consider rectal administration.

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.